Loading...
CannLabs, Inc.
CANL•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)
CannLabs, Inc. (CANL) Stock Overview
Explore CannLabs, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for CANLStats details for CANL are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CANLAnalyst Recommendations details for CANL are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.
CEO
Mr. Mark C. Mirken
Employees
37
Headquarters
3888 East Mexico Avenue, Denver, CO
Founded
2014